Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Heterotopic auxiliary segment 2-3 liver transplantation with delayed total hepatectomy: New strategies for nonresectable colorectal liver metastases.
Ravaioli M, Fallani G, Cescon M, Prosperi E, De Pace V, Siniscalchi A, Sangiorgi G, Ferracin M, Ardizzoni A, Morelli MC, Garajová I. Ravaioli M, et al. Among authors: ferracin m. Surgery. 2018 Sep;164(3):601-603. doi: 10.1016/j.surg.2018.05.021. Epub 2018 Jul 2. Surgery. 2018. PMID: 30041968 No abstract available.
MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma-a step towards personalized therapy.
Garajová I, Funel N, Fiorentino M, Agostini V, Ferracin M, Negrini M, Frassineti GL, Gavelli G, Frampton AE, Biasco G, Giovannetti E. Garajová I, et al. Among authors: ferracin m. Clin Epigenetics. 2015 Dec 16;7:129. doi: 10.1186/s13148-015-0162-5. eCollection 2015. Clin Epigenetics. 2015. PMID: 26677401 Free PMC article.
LncRNAs as novel players in hepatocellular carcinoma recurrence.
Gramantieri L, Baglioni M, Fornari F, Laginestra MA, Ferracin M, Indio V, Ravaioli M, Cescon M, De Pace V, Leoni S, Coadă CA, Negrini M, Bolondi L, Giovannini C. Gramantieri L, et al. Among authors: ferracin m. Oncotarget. 2018 Oct 12;9(80):35085-35099. doi: 10.18632/oncotarget.26202. eCollection 2018 Oct 12. Oncotarget. 2018. PMID: 30416681 Free PMC article.
KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC.
Cinausero M, Laprovitera N, De Maglio G, Gerratana L, Riefolo M, Macerelli M, Fiorentino M, Porcellini E, Buoro V, Gelsomino F, Squadrilli A, Fasola G, Negrini M, Tiseo M, Ferracin M, Ardizzoni A. Cinausero M, et al. Among authors: ferracin m. Ther Adv Med Oncol. 2019 Nov 14;11:1758835919885540. doi: 10.1177/1758835919885540. eCollection 2019. Ther Adv Med Oncol. 2019. PMID: 31798692 Free PMC article.
MiR-30e-3p Influences Tumor Phenotype through MDM2/TP53 Axis and Predicts Sorafenib Resistance in Hepatocellular Carcinoma.
Gramantieri L, Pollutri D, Gagliardi M, Giovannini C, Quarta S, Ferracin M, Casadei-Gardini A, Callegari E, De Carolis S, Marinelli S, Benevento F, Vasuri F, Ravaioli M, Cescon M, Piscaglia F, Negrini M, Bolondi L, Fornari F. Gramantieri L, et al. Among authors: ferracin m. Cancer Res. 2020 Apr 15;80(8):1720-1734. doi: 10.1158/0008-5472.CAN-19-0472. Epub 2020 Feb 3. Cancer Res. 2020. PMID: 32015093
MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary.
Laprovitera N, Riefolo M, Porcellini E, Durante G, Garajova I, Vasuri F, Aigelsreiter A, Dandachi N, Benvenuto G, Agostinis F, Sabbioni S, Berindan Neagoe I, Romualdi C, Ardizzoni A, Trerè D, Pichler M, D'Errico A, Ferracin M. Laprovitera N, et al. Among authors: ferracin m. Mol Oncol. 2021 Oct;15(10):2732-2751. doi: 10.1002/1878-0261.13026. Epub 2021 Jun 23. Mol Oncol. 2021. PMID: 34075699 Free PMC article.
Genetic Characterization of Cancer of Unknown Primary Using Liquid Biopsy Approaches.
Laprovitera N, Salamon I, Gelsomino F, Porcellini E, Riefolo M, Garonzi M, Tononi P, Valente S, Sabbioni S, Fontana F, Manaresi N, D'Errico A, Pantaleo MA, Ardizzoni A, Ferracin M. Laprovitera N, et al. Among authors: ferracin m. Front Cell Dev Biol. 2021 Jun 10;9:666156. doi: 10.3389/fcell.2021.666156. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34178989 Free PMC article.
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer.
Mazzeschi M, Sgarzi M, Romaniello D, Gelfo V, Cavallo C, Ambrosi F, Morselli A, Miano C, Laprovitera N, Girone C, Ferracin M, Santi S, Rihawi K, Ardizzoni A, Fiorentino M, D'Uva G, Győrffy B, Palmer R, Lauriola M. Mazzeschi M, et al. Among authors: ferracin m. J Exp Clin Cancer Res. 2022 Mar 29;41(1):113. doi: 10.1186/s13046-022-02309-1. J Exp Clin Cancer Res. 2022. PMID: 35351152 Free PMC article.
188 results